Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 197 entries
Sorted by: Best Match Show Resources per page
Geophysics. Longitudinal variation in springtime ozone trends.

Nature

Knudsen BM, Andersen SB.
PMID: 11607021
Nature. 2001 Oct 18;413(6857):699-700. doi: 10.1038/35099677.

Satellite measurements indicate that mid-latitude ozone depletion in the Northern Hemisphere spring during 1979-97 was worst over Europe and Russia. Here we show that these longitudinal differences in ozone trends are due to a combination of decadal variations in...

Cite
Knudsen BM, Andersen SB. Geophysics. Longitudinal variation in springtime ozone trends. Nature. 2001;413(6857):699-700doi: 10.1038/35099677.
Knudsen, B. M., & Andersen, S. B. (2001). Geophysics. Longitudinal variation in springtime ozone trends. Nature, 413(6857), 699-700. https://doi.org/10.1038/35099677
Knudsen, B M, and Andersen, S B. "Geophysics. Longitudinal variation in springtime ozone trends." Nature vol. 413,6857 (2001): 699-700. doi: https://doi.org/10.1038/35099677
Knudsen BM, Andersen SB. Geophysics. Longitudinal variation in springtime ozone trends. Nature. 2001 Oct 18;413(6857):699-700. doi: 10.1038/35099677. PMID: 11607021.
Copy Download .nbib Format: NLM
Measurement of ozone injury by determination of leaf chlorophyll concentration.

Plant physiology

Knudson LL, Tibbitts TW, Edwards GE.
PMID: 16660147
Plant Physiol. 1977 Oct;60(4):606-8. doi: 10.1104/pp.60.4.606.

A simple, rapid procedure is described for evaluating ozone injury to leaves of Phaseolus vulgaris L. cv. Pinto. Leaf chlorophyll is extracted with ethanol and analyzed spectrophotometrically; the concentration is expressed on the basis of leaf dry weight.The per...

Cite
Knudson LL, Tibbitts TW, Edwards GE. Measurement of ozone injury by determination of leaf chlorophyll concentration. Plant Physiol. 1977;60(4):606-8doi: 10.1104/pp.60.4.606.
Knudson, L. L., Tibbitts, T. W., & Edwards, G. E. (1977). Measurement of ozone injury by determination of leaf chlorophyll concentration. Plant physiology, 60(4), 606-8. https://doi.org/10.1104/pp.60.4.606
Knudson, L L, et al. "Measurement of ozone injury by determination of leaf chlorophyll concentration." Plant physiology vol. 60,4 (1977): 606-8. doi: https://doi.org/10.1104/pp.60.4.606
Knudson LL, Tibbitts TW, Edwards GE. Measurement of ozone injury by determination of leaf chlorophyll concentration. Plant Physiol. 1977 Oct;60(4):606-8. doi: 10.1104/pp.60.4.606. PMID: 16660147; PMCID: PMC542673.
Copy Download .nbib Format: NLM
Chronic fatigue syndrome in the media: a content analysis of newspaper articles.

JRSM short reports

Knudsen AK, Omenås AN, Harvey SB, Løvvik CM, Lervik LV, Mykletun A.
PMID: 21637403
JRSM Short Rep. 2011 May;2(5):42. doi: 10.1258/shorts.2011.011016. Epub 2011 May 25.

OBJECTIVES: Although cognitive behavioural therapy and graded exercise treatment are recognized evidence-based treatments for chronic fatigue syndrome/myalgic encephalomyelitis (ME), their use is still considered controversial by some patient groups. This debate has been reflected in the media, where many...

Cite
Knudsen AK, Omenås AN, Harvey SB, et al. Chronic fatigue syndrome in the media: a content analysis of newspaper articles. JRSM Short Rep. 2011;2(5):42doi: 10.1258/shorts.2011.011016.
Knudsen, A. K., Omenås, A. N., Harvey, S. B., Løvvik, C. M., Lervik, L. V., & Mykletun, A. (2011). Chronic fatigue syndrome in the media: a content analysis of newspaper articles. JRSM short reports, 2(5), 42. https://doi.org/10.1258/shorts.2011.011016
Knudsen, Ann Kristen, et al. "Chronic fatigue syndrome in the media: a content analysis of newspaper articles." JRSM short reports vol. 2,5 (2011): 42. doi: https://doi.org/10.1258/shorts.2011.011016
Knudsen AK, Omenås AN, Harvey SB, Løvvik CM, Lervik LV, Mykletun A. Chronic fatigue syndrome in the media: a content analysis of newspaper articles. JRSM Short Rep. 2011 May;2(5):42. doi: 10.1258/shorts.2011.011016. Epub 2011 May 25. PMID: 21637403; PMCID: PMC3105457.
Copy Download .nbib Format: NLM
Thermal dissociation of molten KHSO4: temperature dependence of Raman spectra and thermodynamics.

The journal of physical chemistry. B

Knudsen CB, Kalampounias AG, Fehrmann R, Boghosian S.
PMID: 18767773
J Phys Chem B. 2008 Sep 25;112(38):11996-2000. doi: 10.1021/jp801853z. Epub 2008 Sep 03.

Raman spectroscopy is used to study the thermal dissociation of molten KHSO4 at temperatures of 240-450 degrees C under static equilibrium conditions. Raman spectra obtained at 10 different temperatures for the molten phase and for the vapors thereof exhibit...

Cite
Knudsen CB, Kalampounias AG, Fehrmann R, et al. Thermal dissociation of molten KHSO4: temperature dependence of Raman spectra and thermodynamics. J Phys Chem B. 2008;112(38):11996-2000doi: 10.1021/jp801853z.
Knudsen, C. B., Kalampounias, A. G., Fehrmann, R., & Boghosian, S. (2008). Thermal dissociation of molten KHSO4: temperature dependence of Raman spectra and thermodynamics. The journal of physical chemistry. B, 112(38), 11996-2000. https://doi.org/10.1021/jp801853z
Knudsen, Christian B, et al. "Thermal dissociation of molten KHSO4: temperature dependence of Raman spectra and thermodynamics." The journal of physical chemistry. B vol. 112,38 (2008): 11996-2000. doi: https://doi.org/10.1021/jp801853z
Knudsen CB, Kalampounias AG, Fehrmann R, Boghosian S. Thermal dissociation of molten KHSO4: temperature dependence of Raman spectra and thermodynamics. J Phys Chem B. 2008 Sep 25;112(38):11996-2000. doi: 10.1021/jp801853z. Epub 2008 Sep 03. PMID: 18767773.
Copy Download .nbib Format: NLM
Changes in plasma IL-6, plasma VEGF and serum YKL-40 during Treatment with Etanercept and Methotrexate or Etanercept alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy.

Biomarker insights

Knudsen LS, Hetland ML, Johansen JS, Skjødt H, Peters ND, Colic A, Grau K, Nielsen HJ, Ostergaard M.
PMID: 20029652
Biomark Insights. 2009 Sep 23;4:91-5. doi: 10.4137/bmi.s2300.

Changes in plasma IL-6, plasma VEGF and serum YKL-40 were determined in rheumatoid arthritis (RA) patients during treatment with etanercept alone or in combination with methotrexate. Twenty-five patients with active RA (DAS28 >/= 3.2) were randomized to receive etanercept...

Cite
Knudsen LS, Hetland ML, Johansen JS, et al. Changes in plasma IL-6, plasma VEGF and serum YKL-40 during Treatment with Etanercept and Methotrexate or Etanercept alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy. Biomark Insights. 2009;4:91-5doi: 10.4137/bmi.s2300.
Knudsen, L. S., Hetland, M. L., Johansen, J. S., Skjødt, H., Peters, N. D., Colic, A., Grau, K., Nielsen, H. J., & Ostergaard, M. (2009). Changes in plasma IL-6, plasma VEGF and serum YKL-40 during Treatment with Etanercept and Methotrexate or Etanercept alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy. Biomarker insights, 491-5. https://doi.org/10.4137/bmi.s2300
Knudsen, Lene Surland, et al. "Changes in plasma IL-6, plasma VEGF and serum YKL-40 during Treatment with Etanercept and Methotrexate or Etanercept alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy." Biomarker insights vol. 4 (2009): 91-5. doi: https://doi.org/10.4137/bmi.s2300
Knudsen LS, Hetland ML, Johansen JS, Skjødt H, Peters ND, Colic A, Grau K, Nielsen HJ, Ostergaard M. Changes in plasma IL-6, plasma VEGF and serum YKL-40 during Treatment with Etanercept and Methotrexate or Etanercept alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy. Biomark Insights. 2009 Sep 23;4:91-5. doi: 10.4137/bmi.s2300. PMID: 20029652; PMCID: PMC2796864.
Copy Download .nbib Format: NLM
Computer disease simulation models: integrating evidence for health policy.

Academic radiology

Rutter CM, Knudsen AB, Pandharipande PV.
PMID: 21435924
Acad Radiol. 2011 Sep;18(9):1077-86. doi: 10.1016/j.acra.2011.02.004. Epub 2011 Mar 23.

Computer disease simulation models are increasingly being used to evaluate and inform health care decisions across medical disciplines. The aim of researchers who develop these models is to integrate and synthesize short-term outcomes and results from multiple sources to...

Cite
Rutter CM, Knudsen AB, Pandharipande PV. Computer disease simulation models: integrating evidence for health policy. Acad Radiol. 2011;18(9):1077-86doi: 10.1016/j.acra.2011.02.004.
Rutter, C. M., Knudsen, A. B., & Pandharipande, P. V. (2011). Computer disease simulation models: integrating evidence for health policy. Academic radiology, 18(9), 1077-86. https://doi.org/10.1016/j.acra.2011.02.004
Rutter, Carolyn M, et al. "Computer disease simulation models: integrating evidence for health policy." Academic radiology vol. 18,9 (2011): 1077-86. doi: https://doi.org/10.1016/j.acra.2011.02.004
Rutter CM, Knudsen AB, Pandharipande PV. Computer disease simulation models: integrating evidence for health policy. Acad Radiol. 2011 Sep;18(9):1077-86. doi: 10.1016/j.acra.2011.02.004. Epub 2011 Mar 23. PMID: 21435924; PMCID: PMC3125421.
Copy Download .nbib Format: NLM
Diabetes, glycemic control and risk of medical glaucoma treatment: A population-based case-control study.

Clinical epidemiology

Welinder LG, Riis AH, Knudsen LL, Thomsen RW.
PMID: 20865094
Clin Epidemiol. 2009 Aug 09;1:125-31. doi: 10.2147/clep.s6831.

PURPOSE: To examine the association between diabetes and risk of medical glaucoma treatment and to assess the role of long-term glycemic control in the putative association.DESIGN: Population-based case-control study.METHODS: Cases of treated glaucoma were all persons filling at least...

Cite
Welinder LG, Riis AH, Knudsen LL, et al. Diabetes, glycemic control and risk of medical glaucoma treatment: A population-based case-control study. Clin Epidemiol. 2009;1:125-31doi: 10.2147/clep.s6831.
Welinder, L. G., Riis, A. H., Knudsen, L. L., & Thomsen, R. W. (2009). Diabetes, glycemic control and risk of medical glaucoma treatment: A population-based case-control study. Clinical epidemiology, 1125-31. https://doi.org/10.2147/clep.s6831
Welinder, Lotte G, et al. "Diabetes, glycemic control and risk of medical glaucoma treatment: A population-based case-control study." Clinical epidemiology vol. 1 (2009): 125-31. doi: https://doi.org/10.2147/clep.s6831
Welinder LG, Riis AH, Knudsen LL, Thomsen RW. Diabetes, glycemic control and risk of medical glaucoma treatment: A population-based case-control study. Clin Epidemiol. 2009 Aug 09;1:125-31. doi: 10.2147/clep.s6831. PMID: 20865094; PMCID: PMC2943166.
Copy Download .nbib Format: NLM
An eEF1A1 truncation encoded by PTI-1 exerts its oncogenic effect inside the nucleus.

Cancer cell international

Dahl LD, Corydon TJ, Ränkel L, Nielsen KM, Füchtbauer EM, Knudsen CR.
PMID: 24571548
Cancer Cell Int. 2014 Feb 26;14(1):17. doi: 10.1186/1475-2867-14-17.

BACKGROUND: The oncogene PTI-1 was originally isolated from a prostate cancer cell line by its capability to transform rat fibroblasts. The PTI-1 mRNA has a very eccentric structure as the 5'UTR is similar to prokaryotic 23S rRNA, while the...

Cite
Dahl LD, Corydon TJ, Ränkel L, et al. An eEF1A1 truncation encoded by PTI-1 exerts its oncogenic effect inside the nucleus. Cancer Cell Int. 2014;14(1):17doi: 10.1186/1475-2867-14-17.
Dahl, L. D., Corydon, T. J., Ränkel, L., Nielsen, K. M., Füchtbauer, E. M., & Knudsen, C. R. (2014). An eEF1A1 truncation encoded by PTI-1 exerts its oncogenic effect inside the nucleus. Cancer cell international, 14(1), 17. https://doi.org/10.1186/1475-2867-14-17
Dahl, Louise D, et al. "An eEF1A1 truncation encoded by PTI-1 exerts its oncogenic effect inside the nucleus." Cancer cell international vol. 14,1 (2014): 17. doi: https://doi.org/10.1186/1475-2867-14-17
Dahl LD, Corydon TJ, Ränkel L, Nielsen KM, Füchtbauer EM, Knudsen CR. An eEF1A1 truncation encoded by PTI-1 exerts its oncogenic effect inside the nucleus. Cancer Cell Int. 2014 Feb 26;14(1):17. doi: 10.1186/1475-2867-14-17. PMID: 24571548; PMCID: PMC3941776.
Copy Download .nbib Format: NLM
Microscopy-based quantitative analysis of lung structure: application in diagnosis.

Expert opinion on medical diagnostics

Knudsen L, Ochs M.
PMID: 23484552
Expert Opin Med Diagn. 2011 Jul;5(4):319-31. doi: 10.1517/17530059.2011.577414. Epub 2011 Jun 21.

INTRODUCTION: Stereology provides a set of methods that are appropriate for a microscopy-based quantitative assessment of lung structure. In general, the aim of stereology is to obtain information on three-dimensional structures from two-dimensional sections of these structures. The inherent...

Cite
Knudsen L, Ochs M. Microscopy-based quantitative analysis of lung structure: application in diagnosis. Expert Opin Med Diagn. 2011;5(4):319-31doi: 10.1517/17530059.2011.577414.
Knudsen, L., & Ochs, M. (2011). Microscopy-based quantitative analysis of lung structure: application in diagnosis. Expert opinion on medical diagnostics, 5(4), 319-31. https://doi.org/10.1517/17530059.2011.577414
Knudsen, Lars, and Ochs, Matthias. "Microscopy-based quantitative analysis of lung structure: application in diagnosis." Expert opinion on medical diagnostics vol. 5,4 (2011): 319-31. doi: https://doi.org/10.1517/17530059.2011.577414
Knudsen L, Ochs M. Microscopy-based quantitative analysis of lung structure: application in diagnosis. Expert Opin Med Diagn. 2011 Jul;5(4):319-31. doi: 10.1517/17530059.2011.577414. Epub 2011 Jun 21. PMID: 23484552.
Copy Download .nbib Format: NLM
Lixisenatide in the treatment of Type 2 diabetes.

Expert review of endocrinology & metabolism

Donsmark M, Knudsen LB.
PMID: 30736157
Expert Rev Endocrinol Metab. 2014 May;9(3):197-199. doi: 10.1586/17446651.2014.897604. Epub 2014 Mar 29.

No abstract available.

Cite
Donsmark M, Knudsen LB. Lixisenatide in the treatment of Type 2 diabetes. Expert Rev Endocrinol Metab. 2014;9(3):197-199doi: 10.1586/17446651.2014.897604.
Donsmark, M., & Knudsen, L. B. (2014). Lixisenatide in the treatment of Type 2 diabetes. Expert review of endocrinology & metabolism, 9(3), 197-199. https://doi.org/10.1586/17446651.2014.897604
Donsmark, Morten, and Knudsen, Lotte Bjerre. "Lixisenatide in the treatment of Type 2 diabetes." Expert review of endocrinology & metabolism vol. 9,3 (2014): 197-199. doi: https://doi.org/10.1586/17446651.2014.897604
Donsmark M, Knudsen LB. Lixisenatide in the treatment of Type 2 diabetes. Expert Rev Endocrinol Metab. 2014 May;9(3):197-199. doi: 10.1586/17446651.2014.897604. Epub 2014 Mar 29. PMID: 30736157.
Copy Download .nbib Format: NLM
Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens.

Oncoimmunology

van de Wall S, Ljungberg K, Ip PP, Boerma A, Knudsen ML, Nijman HW, Liljeström P, Daemen T.
PMID: 30288352
Oncoimmunology. 2018 Jul 26;7(10):e1487913. doi: 10.1080/2162402X.2018.1487913. eCollection 2018.

Cervical cancer develops as a result of infection with high-risk human papillomavirus (HPV) through persistent expression of early proteins E6 and E7. Our group pioneered a recombinant viral vector system based on Semliki Forest virus (SFV) for vaccination against...

Cite
van de Wall S, Ljungberg K, Ip PP, et al. Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens. Oncoimmunology. 2018;7(10):e1487913doi: 10.1080/2162402X.2018.1487913.
van de Wall, S., Ljungberg, K., Ip, P. P., Boerma, A., Knudsen, M. L., Nijman, H. W., Liljeström, P., & Daemen, T. (2018). Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens. Oncoimmunology, 7(10), e1487913. https://doi.org/10.1080/2162402X.2018.1487913
van de Wall, Stephanie, et al. "Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens." Oncoimmunology vol. 7,10 (2018): e1487913. doi: https://doi.org/10.1080/2162402X.2018.1487913
van de Wall S, Ljungberg K, Ip PP, Boerma A, Knudsen ML, Nijman HW, Liljeström P, Daemen T. Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens. Oncoimmunology. 2018 Jul 26;7(10):e1487913. doi: 10.1080/2162402X.2018.1487913. eCollection 2018. PMID: 30288352; PMCID: PMC6169581.
Copy Download .nbib Format: NLM
The UV-visible action-absorption spectrum of all-trans and 11-cis protonated Schiff base retinal in the gas phase.

Physical chemistry chemical physics : PCCP

Knudsen JL, Kluge A, Bochenkova AV, Kiefer HV, Andersen LH.
PMID: 29480305
Phys Chem Chem Phys. 2018 Mar 07;20(10):7190-7194. doi: 10.1039/c7cp07512j.

The UV-visible absorption of retinal in its protonated Schiff-base form is studied in the gas phase. In particular, transitions to highly-excited electronic states, S

Cite
Knudsen JL, Kluge A, Bochenkova AV, et al. The UV-visible action-absorption spectrum of all-trans and 11-cis protonated Schiff base retinal in the gas phase. Phys Chem Chem Phys. 2018;20(10):7190-7194doi: 10.1039/c7cp07512j.
Knudsen, J. L., Kluge, A., Bochenkova, A. V., Kiefer, H. V., & Andersen, L. H. (2018). The UV-visible action-absorption spectrum of all-trans and 11-cis protonated Schiff base retinal in the gas phase. Physical chemistry chemical physics : PCCP, 20(10), 7190-7194. https://doi.org/10.1039/c7cp07512j
Knudsen, Jeppe Langeland, et al. "The UV-visible action-absorption spectrum of all-trans and 11-cis protonated Schiff base retinal in the gas phase." Physical chemistry chemical physics : PCCP vol. 20,10 (2018): 7190-7194. doi: https://doi.org/10.1039/c7cp07512j
Knudsen JL, Kluge A, Bochenkova AV, Kiefer HV, Andersen LH. The UV-visible action-absorption spectrum of all-trans and 11-cis protonated Schiff base retinal in the gas phase. Phys Chem Chem Phys. 2018 Mar 07;20(10):7190-7194. doi: 10.1039/c7cp07512j. PMID: 29480305.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 197 entries